BERGEN BRUNSWIG CORP

Bergen Brunswig Corp., listed under CIK 11454, operates within the pharmaceutical distribution space defined by SIC codes related to drug wholesalers, where it has historically supplied a wide range of branded and generic medications alongside patient-support services to hospitals, community pharmacies, and clinical providers. While the specific industry classification remains unspecified, the company’s core services sit squarely in the logistics-driven, compliance-heavy world of healthcare supply chains, emphasizing reliability, temperature-controlled storage, and inventory management to meet its customers’ demand for timely and accurate fulfillment. Clients rely on Bergen Brunswig to navigate ever-tightening FDA and DEA oversight, track controlled substances, and comply with state-level pharmacy board requirements, making regulatory diligence a material risk alongside the need to absorb cost pressures from payer reimbursement policies and macroeconomic shifts in drug pricing. Investors and industry watchers can view live SEC filings on Earnings Feed to stay current with Bergen Brunswig’s disclosures.

Source: Earnings Feed research · last updated 11/24/2025